Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 5381 - 500 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Reset ↻

Assertio Reports Fourth Quarter and Full Year 2023 Financial Results

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Assertio Holdings, Inc.

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Rhythm Pharmaceuticals, Inc.

Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Terns Pharmaceuticals Inc.

SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: SeaStar Medical

ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Oric Pharmaceuticals Inc.

Crinetics Pharmaceuticals Announces March 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Crinetics Pharmaceuticals, Inc.

LifeMD Reports Fourth Quarter 2023 Results

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: LifeMD, Inc

NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: NGM Biopharmaceuticals, Inc.

Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2023 Results

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Ocular Therapeutix, Inc.

Larimar Therapeutics Announces the Dosing of the First Patient in Long-term Open Label Extension Study for Nomlabofusp in Patients with Friedreich’s Ataxia

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Larimar Therapeutics, Inc.

Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: MindBio Therapeutics Corp

Cognition Therapeutics Announces Proposed Public Offering of Common Stock

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Cognition Therapeutics, Inc.

Eupraxia Pharmaceuticals Announces Overnight Marketed Offering of Approximately $30 Million

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Eupraxia Pharmaceuticals Inc.

CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: CytomX Therapeutics, Inc.

BioRestorative Therapies to Participate in the 36th Annual ROTH Conference

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: BioRestorative Therapies, Inc.

Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: AnaptysBio, Inc.

Foundation Health Secures $6 Million in Seed Funding to Power the Next Generation of Consumer Healthcare Experiences

Read more ››

By: GlobeNewswire - 11 Mar 2024

Assure Holdings Enters into Agreement to Sell Certain of its Assets to MPOWERHealth

Read more ››

By: GlobeNewswire - 11 Mar 2024

Appointment of Dr Darren Patti to Group Chief Operating Officer

Read more ››

By: PR Newswire Association LLC. - 11 Mar 2024

Related companies: Telix Pharmaceuticals Limited

FDA Seeks $7.2 Billion to Enhance Food Safety and Nutrition, Advance Medical Product Safety, and Strengthen Public Health

Read more ››

By: PR Newswire Association LLC. - 11 Mar 2024

Related companies: U.S. Food and Drug Administration

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

to the top ↑